Status:
COMPLETED
Evaluation of Anterior Repositioning Guided Splint Combined With or Without I Platelet-rich Fibrin
Lead Sponsor:
Mahmoud Mohammed Mahmoud Nasef
Conditions:
Temporomandibular Joint Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to evaluate clinically and radiographically the effectiveness of arthrocentesis and injection of I-PRF with wearing ARS in comparison to arthrocentesis and ARS only.
Detailed Description
The patient will be seated at a 45° angle with the head turned toward the unaffected side. After preparing and disinfecting the target site with betadine, two points will be marked over the affected j...
Eligibility Criteria
Inclusion
- Adults aged 18 years and older.
- History of unilateral or bilateral disc displacement without reduction (DDwoR) of the temporomandibular joint (TMJ) confirmed by MRI.
- Presence of TMJ pain and restricted maximum mouth opening.
- No improvement with conservative treatment.
- Absence of MRI contraindications.
Exclusion
- Patients having any systemic disease that could interfere with the TMJ treatment or assessment.
- Patients having previous TMD treatment modalities or previous TMJ surgery.
- Patients with a previous history of oral and or maxillofacial trauma.
- Patients that are contraindicated to perform MRI.
- Completely or partially edentulous patients were also excluded.
Key Trial Info
Start Date :
October 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 14 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06132802
Start Date
October 2 2021
End Date
October 14 2022
Last Update
November 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dental Medicine Al-Azhar University
Asyut, Egypt